US 11090285
Treatment of circadian rhythm disorders
granted A61KA61K31/15A61K31/277
Quick answer
US patent 11090285 (Treatment of circadian rhythm disorders) held by VANDA PHARMACEUTICALS INC. expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/15, A61K31/277, A61K31/31, A61K31/343